Merck & Co., Inc. is a Public Company based in Kenilworth, NJ led by Robert M. Davis, managing $217.8M across 11 long positions as of Q3 2025 with 98% Healthcare concentration, 100% concentrated in top 10 holdings, and 42% allocation to PSNL.
Largest long holdings in Merck & Co., Inc.'s portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Medical - Diagnostics & Research Healthcare | $91.6M | 42.04% | — | 15.84% 14.0M shares | |
Biotechnology Healthcare | $59.6M | 27.37% | — | 0.59% 2.3M shares | |
Biotechnology Healthcare | $43.7M | 20.06% | — | 1.08% 772.2K shares | |
Biotechnology Healthcare | $10.5M | 4.82% | — | 3.50% 3.5M shares | |
Unknown Unknown | $4.6M | 2.10% | — | — 1.2M shares | |
Biotechnology Healthcare | $2.4M | 1.09% | — | 3.21% 2.7M shares | |
Biotechnology Healthcare | $2.0M | 0.93% | — | 0.11% 93.4K shares | |
Biotechnology Healthcare | $1.8M | 0.82% | — | 4.37% 1.1M shares | |
Biotechnology Healthcare | $1.3M | 0.57% | — | 2.86% 1.5M shares | |
Biotechnology Healthcare | $403.7K | 0.19% | — | 3.53% 1.5M shares |
Portfolio insights and performance metrics for Merck & Co., Inc.
We use cookies for analytics. See our Privacy and Cookie Policy.